Trazodone Mechanism of Action
Trazodone functions primarily as a dual-action antidepressant: it selectively inhibits serotonin reuptake (SSRI activity) while simultaneously antagonizing 5-HT2A serotonin receptors, with the 5-HT2A receptor antagonism likely being its most potent pharmacological effect. 1, 2
Primary Mechanisms
Serotonergic Actions
- Serotonin reuptake inhibition: Trazodone selectively blocks neuronal reuptake of serotonin with a binding affinity (Ki) of 367 nM, though this is weaker than its receptor antagonism 1
- 5-HT2A receptor antagonism: The most potent action occurs at 5-HT2A receptors (Ki = 35.6 nM), which distinguishes trazodone from pure SSRIs and may explain its unique clinical profile including sleep benefits and lack of sexual dysfunction 1, 2
- Additional serotonin receptor effects: Acts as an antagonist at 5-HT2B (Ki = 78.4 nM) and 5-HT2C (Ki = 224 nM) receptors, and as a partial agonist at 5-HT1A receptors (Ki = 118 nM) 1
Adrenergic Actions
- Alpha-1 adrenergic receptor antagonism: Blocks α1A receptors (Ki = 153 nM), which accounts for orthostatic hypotension and sedative effects 1
- Alpha-2C receptor antagonism: Also antagonizes α2C receptors (Ki = 155 nM) 1
Classification and Clinical Implications
Trazodone belongs to the serotonin antagonist and reuptake inhibitor (SARI) class, differentiating it from pure SSRIs like fluoxetine 3, 4. This dual mechanism—combining 5-HT2A antagonism with serotonin reuptake inhibition—produces a distinct therapeutic profile that overcomes common SSRI tolerability issues including insomnia, anxiety, and sexual dysfunction 3.
Key Mechanistic Distinctions
- Unlike fluoxetine (where serotonin reuptake inhibition is the dominant action), trazodone's most potent effect is 5-HT2 receptor antagonism rather than reuptake inhibition 2
- The net effect on serotonergic transmission from this dual action remains incompletely understood, and its precise role in antidepressant efficacy is not fully elucidated 1
- This mechanism explains why trazodone is effective for depression but ineffective for obsessive-compulsive disorder and panic disorder (conditions that respond to pure serotonin reuptake inhibition) 2
Active Metabolite
- Trazodone undergoes oxidative cleavage via CYP3A4 to form m-chlorophenylpiperazine (mCPP), an active metabolite that contributes to clinical effects 1, 5
- Less than 1% of trazodone is excreted unchanged, indicating extensive metabolism 1
Common Pitfall to Avoid
Do not classify trazodone simply as an "SSRI"—while it does inhibit serotonin reuptake, its most clinically relevant action is 5-HT2A receptor antagonism, which fundamentally distinguishes its therapeutic profile and side effect profile from traditional SSRIs 2, 3.